Table 4.
Potential Biomarker | Study Population (n) | Sample | Results | Possible Utility |
---|---|---|---|---|
MBP | RRMS (31), CIS (18) | CSF | Correlated with EDSS scores [89] | Prognostic |
Acute exacerbation of MS (15), remission (19), slow progressive form (13) | CSF | MS patients with an acute exacerbation had higher levels than those with slower progressive MS and even higher than those in remission [90] | ||
MOG | RRMS (2), anti-MOG (1) | CSF | Distinct myeloid cell types if subjects with neuroinflammation [93] | Diagnostic |
MBP = myelin basic protein; MOG = myelin oligodendrocyte glycoprotein.